These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 9269682)

  • 1. Heterozygosity for factor V Leiden in a haemodialysis patient with recurrent shunt thrombosis.
    Bremer C; Schaefer RM
    Nephrol Dial Transplant; 1997 Aug; 12(8):1775-6. PubMed ID: 9269682
    [No Abstract]   [Full Text] [Related]  

  • 2. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recurrent thrombosis due to compound heterozygosity for factor V Leiden and factor V deficiency.
    Zehnder JL; Jain M
    Blood Coagul Fibrinolysis; 1996 Apr; 7(3):361-2. PubMed ID: 8735145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Recurrent vascular access trombosis associated with the prothrombin mutation G20210A in a adult patient in haemodialysis].
    Quintana LF; Coll E; Monteagudo I; Collado S; López-Pedret J; Cases A
    Nefrologia; 2005; 25(4):442-4. PubMed ID: 16231514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Catheter-associated recurrent intracardiac thrombosis and factor V Leiden mutation in a child with non-Hodgkin's lymphoma.
    Corapçioğlu F; Uysal KM; Silistreli E; Unal N; Oren H; Açikel U
    Turk J Pediatr; 2005; 47(3):279-82. PubMed ID: 16250317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic prothrombotic mutations are common in neonates but are not associated with umbilical catheter-associated thrombosis.
    Turebylu R; Salis R; Erbe R; Martin D; Lakshminrusimha S; Ryan RM
    J Perinatol; 2007 Aug; 27(8):490-5. PubMed ID: 17625574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent haemodialysis vascular access thrombosis in a patient with factor V Leiden.
    Llamas-Álvarez A; Enríquez R; Sirvent AE; Redondo-Pachón MD; Millán I; Araque A; Amorós F
    Nefrologia; 2013; 33(4):604-5. PubMed ID: 23897196
    [No Abstract]   [Full Text] [Related]  

  • 8. Is hyperhomocysteinaemia a risk factor for recurrent vascular access thrombosis in haemodialysis patients?
    Ducloux D; Pascal B; Jamali M; Gibey R; Chalopin JM
    Nephrol Dial Transplant; 1997 Sep; 12(9):2037-8. PubMed ID: 9306379
    [No Abstract]   [Full Text] [Related]  

  • 9. Thrombosis involving the major veins with heterozygote factor V Leiden mutation as the only risk factor.
    Tokgözoğlu SL; Açil T; Haznedaroğlu IC; Aytemir K; Batur MK
    Clin Appl Thromb Hemost; 1999 Jul; 5(3):187-9. PubMed ID: 10726007
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal vein thrombosis in association with factor V Leiden mutation in a patient with hepatocellular carcinoma.
    Gürgey A; Büyükpamukcu M; Baskut C; Yalcin B; Gögüş S
    Med Pediatr Oncol; 1997 Sep; 29(3):224-5. PubMed ID: 9212850
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal thrombosis of renal veins and the inferior vena cava in a newborn with double heterozygosity for the factor V Leiden and prothrombin gene G20210A mutations: a case report.
    Bulut O; Ince Z; Uzunhan O; Coban A
    Blood Coagul Fibrinolysis; 2018 Mar; 29(2):220-222. PubMed ID: 29194072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM; Middeldorp S; Veeger NJ; Hamulyák K; Prins MH; Büller HR; van der Meer J
    Circulation; 2010 Apr; 121(15):1706-12. PubMed ID: 20368522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allergy to latex and repeated vascular access thrombosis in haemodialysis].
    Arenas MD; López-Collado M; Niveiro E; Cotilla de la Rosa E; Morales A; Moledous A; Malek T; Gil MT
    Nefrologia; 2009; 29(4):365-6. PubMed ID: 19668312
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemodialysis vascular access thrombosis: The role of factor V Leiden, prothrombin gene mutation and ABO blood groups.
    Rios DR; Fernandes AP; Carvalho MG; Figueiredo RC; Guimarães DA; Reis DR; Simões e Silva AC; Gomes KB; Dusse LM
    Clin Chim Acta; 2011 Feb; 412(5-6):425-9. PubMed ID: 21070754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The impact of heterozygosity for the factor V Leiden and factor II G20210A mutations on the risk of thrombosis in Greek patients.
    Hatzaki A; Anagnostopoulou E; Metaxa-Mariatou V; Melissinos C; Philalithis P; Iliadis K; Kontaxis A; Liberatos K; Pangratis N; Nasioulas G
    Int Angiol; 2003 Mar; 22(1):79-82. PubMed ID: 12771861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V; Martinelli I; Mannucci PM; Paciaroni K; Chiusolo P; Casorelli I; Rossi E; Leone G
    N Engl J Med; 1999 Sep; 341(11):801-6. PubMed ID: 10477778
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor V Leiden: an overview.
    Shaw DM
    Clin Lab Sci; 2006; 19(4):218-21. PubMed ID: 17181126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early postoperative obstructive prosthetic mitral valve thrombosis in a patient double heterozygous for factor V Leiden and prothrombin G20210A mutation.
    De Paulis S; Rossi E; Zamparelli R; Scapigliati A; Corrado M; De Stefano V
    Thromb Haemost; 2008 Feb; 99(2):441-2. PubMed ID: 18278197
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodialysis access: the case for prospective monitoring.
    Smits JH; Blankestijn PJ
    Curr Opin Nephrol Hypertens; 1999 Nov; 8(6):685-90. PubMed ID: 10630814
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Study of the Leiden mutation (factor VQ 506), the most frequent cause of thrombophilia, in 116 thrombosis patients].
    Nagy A; Melegh B; Losonczy H
    Orv Hetil; 1997 Nov; 138(44):2797-800. PubMed ID: 9411348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.